Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Mark J. Meltzer sold 500 shares of the business’s stock in a transaction that occurred on Tuesday, September 5th. The shares were sold at an average price of $1,025.00, for a total transaction of $512,500.00. Following the completion of the sale, the senior vice president now directly owns 2,796 shares in the company, valued at approximately $2,865,900. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Intuitive Surgical, Inc. (NASDAQ:ISRG) opened at 1022.37 on Thursday. The company has a market cap of $37.98 billion, a price-to-earnings ratio of 48.97 and a beta of 0.38. The stock has a 50 day moving average of $965.62 and a 200-day moving average of $871.33. Intuitive Surgical, Inc. has a one year low of $610.71 and a one year high of $1,029.00. Intuitive Surgical’s stock is set to split on Friday, October 6th. The 3-1 split was announced on Friday, August 11th. The newly created shares will be issued to shareholders after the market closes on Thursday, October 5th.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, July 20th. The medical equipment provider reported $1.98 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.93 by $0.05. Intuitive Surgical had a net margin of 28.44% and a return on equity of 15.99%. The business had revenue of $756.20 million for the quarter, compared to analysts’ expectations of $724.51 million. During the same quarter in the previous year, the business posted $1.87 earnings per share. The business’s revenue was up 12.8% compared to the same quarter last year. On average, equities analysts predict that Intuitive Surgical, Inc. will post $23.92 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This piece was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece on another website, it was stolen and republished in violation of United States & international copyright legislation. The legal version of this piece can be accessed at https://www.thecerbatgem.com/2017/09/07/mark-j-meltzer-sells-500-shares-of-intuitive-surgical-inc-isrg-stock-2.html.

Hedge funds have recently bought and sold shares of the business. ETF Managers Group LLC bought a new position in Intuitive Surgical during the second quarter valued at $110,000. D. Scott Neal Inc. bought a new position in Intuitive Surgical during the second quarter valued at $120,000. Harvest Fund Management Co. Ltd bought a new position in Intuitive Surgical during the second quarter valued at $120,000. Guardian Life Insurance Co. of America increased its position in Intuitive Surgical by 2.2% during the first quarter. Guardian Life Insurance Co. of America now owns 142 shares of the medical equipment provider’s stock valued at $109,000 after acquiring an additional 3 shares during the last quarter. Finally, Parallel Advisors LLC increased its position in Intuitive Surgical by 10.1% during the first quarter. Parallel Advisors LLC now owns 153 shares of the medical equipment provider’s stock valued at $129,000 after acquiring an additional 14 shares during the last quarter. Institutional investors and hedge funds own 94.23% of the company’s stock.

Several research firms have recently issued reports on ISRG. Vetr raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $340.11 price target on the stock in a research report on Thursday, August 17th. Cantor Fitzgerald began coverage on shares of Intuitive Surgical in a research report on Thursday, June 29th. They issued a “neutral” rating and a $333.33 price target on the stock. Morgan Stanley reissued an “overweight” rating and issued a $356.67 price target (up previously from $316.67) on shares of Intuitive Surgical in a research report on Tuesday, July 25th. Canaccord Genuity reaffirmed a “hold” rating and set a $333.33 target price (up previously from $290.00) on shares of Intuitive Surgical in a report on Wednesday, July 26th. Finally, Barclays PLC upped their target price on shares of Intuitive Surgical from $290.00 to $333.33 and gave the stock an “overweight” rating in a report on Friday, July 21st. They noted that the move was a valuation call. Five analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $366.12.

About Intuitive Surgical

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Insider Buying and Selling by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Stock Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related stocks with our FREE daily email newsletter.